Celltrion Launches Remsima SC In UK

Innovative Subcutaneous Infliximab Also Receives Korean Approval

 
• By Dave Wallace

Celltrion has launched Remsima SC in the UK. Meanwhile, the innovative subcutaneous version of biosimilar infliximab has also received approval in Korea.

UK_Map_Blue
Celltrion Has Launched Its Remsima SC In The UK From The Start Of March • Source: Shutterstock

More from Biosimilars

More from Products